Skip to content

Effect of thoracic epidural anesthesia on intraoperative driving pressure in patients undergoing upper abdominal surgery: a randomized controlled trial

Effect of thoracic epidural anesthesia on intraoperative driving pressure in patients undergoing upper abdominal surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068778
Enrollment
Unknown
Registered
2023-02-28
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumors in the upper abdomen (liver, gallbladder/biliary duct, stomach, pancreas, etc.)

Interventions

Experimental group:Intraoperative thoracic epidural anesthesia
Control group:None

Sponsors

The First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective upper abdominal surgery (liver, gallbladder/biliary tract, pancreas, spleen, stomach) with mechanical ventilation; 2. Over 18 years old; 3.ASA Grade I-III; 4. The duration of mechanical ventilation during the operation was more than 120 minutes; 5. The patient and his family members agree and sign the anesthetic consent; 6. Stay in hospital for observation for more than 3 days after surgery; 7. The patient had no cognitive dysfunction before surgery.

Exclusion criteria

Exclusion criteria: 1. The patient or family member refuses, and the patient or family member has severe language communication barriers; 2. There is a high risk of esophageal reflux, and patients who have not strictly fasted water and a full stomach before surgery; 3. Critically ill patients with ASA grade greater than III; 4. Patients with COPD before operation, and Gold grade 3 or above patients; pneumothorax, large amount of pleural effusion (effusion volume> 500ml); 5. NYHA cardiac function grade 3 or above, congenital heart disease, severe arrhythmia; 6. Patients with severe liver and kidney failure; 7. Severely abnormal coagulation function, infection at the puncture site, severe scoliosis, history of spinal trauma, failure of epidural block or catheterization, history of allergy to local anesthetics; Pathological obesity, BMI>35kg/m2, combined with obesity hypoventilation syndrome; 8. Patients with peripheral neuropathy, severe anemia (Hb<30g/L), severe hypoalbuminemia (albumin<20g) or other serious blood diseases.

Design outcomes

Primary

MeasureTime frame
Driving pressure;

Secondary

MeasureTime frame
Postoperative pulmonary complications;Arterial blood gas analysis;Respiratory mechanical indicators (respiratory system compliance, peak airway pressure, mean airway pressure);Hemodynamic indicators (systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate);

Countries

China

Contacts

Public ContactYu Fang

The First Affiliated Hospital of Kunming Medical University

fangyu@ydyy.cn13888091314

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026